Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 449

Similar articles for PubMed (Select 24242678)

1.

MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.

Heinzelmann J, Unrein A, Wickmann U, Baumgart S, Stapf M, Szendroi A, Grimm MO, Gajda MR, Wunderlich H, Junker K.

Ann Surg Oncol. 2014 Mar;21(3):1046-54. doi: 10.1245/s10434-013-3361-3. Epub 2013 Nov 18.

PMID:
24242678
2.

Specific miRNA signatures are associated with metastasis and poor prognosis in clear cell renal cell carcinoma.

Heinzelmann J, Henning B, Sanjmyatav J, Posorski N, Steiner T, Wunderlich H, Gajda MR, Junker K.

World J Urol. 2011 Jun;29(3):367-73. doi: 10.1007/s00345-010-0633-4. Epub 2011 Jan 13.

PMID:
21229250
3.

CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases.

Wuttig D, Zastrow S, Füssel S, Toma MI, Meinhardt M, Kalman K, Junker K, Sanjmyatav J, Boll K, Hackermüller J, Rolle A, Grimm MO, Wirth MP.

Int J Cancer. 2012 Sep 1;131(5):E693-704. doi: 10.1002/ijc.27419. Epub 2012 Feb 28.

PMID:
22213152
4.

miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215.

White NM, Khella HW, Grigull J, Adzovic S, Youssef YM, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Jewett MA, Evans AJ, Gabril M, Yousef GM.

Br J Cancer. 2011 Nov 22;105(11):1741-9. doi: 10.1038/bjc.2011.401. Epub 2011 Oct 27.

5.

Identification of metastamirs as metastasis-associated microRNAs in clear cell renal cell carcinomas.

Wotschofsky Z, Liep J, Meyer HA, Jung M, Wagner I, Disch AC, Schaser KD, Melcher I, Kilic E, Busch J, Weikert S, Miller K, Erbersdobler A, Mollenkopf HJ, Jung K.

Int J Biol Sci. 2012;8(10):1363-74. doi: 10.7150/ijbs.5106. Epub 2012 Oct 28.

6.

miR-129-3p, as a diagnostic and prognostic biomarker for renal cell carcinoma, attenuates cell migration and invasion via downregulating multiple metastasis-related genes.

Chen X, Ruan A, Wang X, Han W, Wang R, Lou N, Ruan H, Qiu B, Yang H, Zhang X.

J Cancer Res Clin Oncol. 2014 Aug;140(8):1295-304. doi: 10.1007/s00432-014-1690-7. Epub 2014 May 7.

PMID:
24802708
7.

miR-141 is a key regulator of renal cell carcinoma proliferation and metastasis by controlling EphA2 expression.

Chen X, Wang X, Ruan A, Han W, Zhao Y, Lu X, Xiao P, Shi H, Wang R, Chen L, Chen S, Du Q, Yang H, Zhang X.

Clin Cancer Res. 2014 May 15;20(10):2617-30. doi: 10.1158/1078-0432.CCR-13-3224. Epub 2014 Mar 19.

8.

Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy.

Slaby O, Jancovicova J, Lakomy R, Svoboda M, Poprach A, Fabian P, Kren L, Michalek J, Vyzula R.

J Exp Clin Cancer Res. 2010 Jul 7;29:90. doi: 10.1186/1756-9966-29-90. Erratum in: J Exp Clin Cancer Res. 2010;29:105.

9.

miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma.

Khella HW, Bakhet M, Allo G, Jewett MA, Girgis AH, Latif A, Girgis H, Von Both I, Bjarnason GA, Yousef GM.

Carcinogenesis. 2013 Oct;34(10):2231-9. doi: 10.1093/carcin/bgt184. Epub 2013 May 28.

10.

Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.

Ma X, Fan Y, Gao Y, Zhang Y, Huang Q, Ai Q, Ni D, Chen W, Zhang P, Song E, Wang B, Shi T, Zheng T, Zhang X.

Urol Oncol. 2014 Jan;32(1):46.e9-17. doi: 10.1016/j.urolonc.2013.06.011. Epub 2013 Oct 4.

PMID:
24094887
12.

A miRNA signature associated with human metastatic medullary thyroid carcinoma.

Santarpia L, Calin GA, Adam L, Ye L, Fusco A, Giunti S, Thaller C, Paladini L, Zhang X, Jimenez C, Trimarchi F, El-Naggar AK, Gagel RF.

Endocr Relat Cancer. 2013 Oct 14;20(6):809-23. doi: 10.1530/ERC-13-0357. Print 2013 Dec.

13.

Genome-wide microRNA expression analysis of clear cell renal cell carcinoma by next generation deep sequencing.

Osanto S, Qin Y, Buermans HP, Berkers J, Lerut E, Goeman JJ, van Poppel H.

PLoS One. 2012;7(6):e38298. doi: 10.1371/journal.pone.0038298. Epub 2012 Jun 20.

14.

MiR-210 expression in tumor tissue and in vitro effects of its silencing in renal cell carcinoma.

Redova M, Poprach A, Besse A, Iliev R, Nekvindova J, Lakomy R, Radova L, Svoboda M, Dolezel J, Vyzula R, Slaby O.

Tumour Biol. 2013 Feb;34(1):481-91. doi: 10.1007/s13277-012-0573-2. Epub 2012 Nov 13.

PMID:
23150176
15.

Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses.

Khella HW, White NM, Faragalla H, Gabril M, Boazak M, Dorian D, Khalil B, Antonios H, Bao TT, Pasic MD, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Jewett MA, Yousef GM.

Tumour Biol. 2012 Feb;33(1):131-40. doi: 10.1007/s13277-011-0255-5. Epub 2011 Nov 16.

PMID:
22086373
16.

The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.

Fritz HK, Lindgren D, Ljungberg B, Axelson H, Dahlbäck B.

Eur J Cancer. 2014 Jul;50(10):1758-65. doi: 10.1016/j.ejca.2014.03.281. Epub 2014 Apr 30.

PMID:
24793999
17.

Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.

Torres A, Torres K, Pesci A, Ceccaroni M, Paszkowski T, Cassandrini P, Zamboni G, Maciejewski R.

Int J Cancer. 2013 Apr 1;132(7):1633-45. doi: 10.1002/ijc.27840. Epub 2012 Oct 17.

PMID:
22987275
18.

Downregulated miR-646 in clear cell renal carcinoma correlated with tumour metastasis by targeting the nin one binding protein (NOB1).

Li W, Liu M, Feng Y, Xu YF, Huang YF, Che JP, Wang GC, Yao XD, Zheng JH.

Br J Cancer. 2014 Sep 9;111(6):1188-200. doi: 10.1038/bjc.2014.382. Epub 2014 Jul 10.

PMID:
25010867
19.

MiRNA-9 and MiRNA-200a distinguish hemangioblastomas from metastatic clear cell renal cell carcinomas in the CNS.

Venneti S, Boateng LA, Friedman JR, Baldwin DA, Tobias JW, Judkins AR, Mourelatos Z, Lal P.

Brain Pathol. 2012 Jul;22(4):522-9. doi: 10.1111/j.1750-3639.2011.00551.x. Epub 2011 Dec 9.

PMID:
22082152
20.

MicroRNA expression in ovarian carcinoma and its correlation with clinicopathological features.

Lee H, Park CS, Deftereos G, Morihara J, Stern JE, Hawes SE, Swisher E, Kiviat NB, Feng Q.

World J Surg Oncol. 2012 Aug 27;10:174.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk